Forward Pharma A/S
CIK 0001604924
Revenue (TTM)
$1.25B
Q2 Jun 2022
Net Income (TTM)
−$1.89M
+70.7% YoY
Q2 Jun 2022
EPS Diluted (TTM)
−$0.02
+71.4% YoY
Q2 Jun 2022
Gross Margin
—
Q2 Jun 2022
Operating Margin
-0.3%
Q2 Jun 2022
Net Margin
-0.2%
Q2 Jun 2022
Free Cash Flow (TTM)
—
Q2 Jun 2022
Cash
$65.28M
Q2 Jun 2022
Total Debt
—
Q2 Jun 2022
Shares Outstanding
98.26M sh
Q2 Jun 2022
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.